abeling of sucralose-containing products in 
general and does not prohibit the use of the health claim in labeling 
of any SPLENDA brand name product that meets Sec.  101.80(c)(2)(iii) 
eligibility criteria.
    (Comment 2) The petitioner commented that FDA incorrectly concluded 
that the use of the dental caries health claim in the labeling of 
SPLENDA Granular would not be appropriate. The petitioner asserted that 
the petition contains insufficient information to warrant this 
conclusion. FDA had